Paracetamol catalyzes myeloperoxidase-initiated lipid oxidation in LDL

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2855-2860

  Kapiotis, S ^a   Sengoelge, G ^b   Hermann, M ^a   Held, I ^a   Seelos, C ^a   Gmeiner, B M K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acetaminophen; Atherosclerosis; Lipid peroxidation; Myeloperoxidase; Oxidized LDL; Paracetamol

Indexed keywords

ALPHA TOCOPHEROL; HEME; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; PARACETAMOL;

ANALGESIA; ARTICLE; ATHEROGENESIS; CATALYSIS; ENZYME ACTIVITY; LIPID OXIDATION; PRIORITY JOURNAL; SPECTROMETRY; STRUCTURE ACTIVITY RELATION;

EID: 0031473786     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2855     Document Type: Article

References (12)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Malterud KE, Farbrot TL, Huse AE, Sund RB. Antioxidant and radical scavenging effects of anthraquinones and anthrones. Pharmacology. 1993;47(suppl 1):77-85.
3. Clifton PM. Antioxidant vitamins and coronary heart disease risk. Curr Opin Lipidol. 1995;6:20-24.
4. Buettner OR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys. 1993;300:535-543.
5. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 1994;269:16712-16719.
6. Pentikainen MO, Lindstedt KA, Kovanen PT. Inhibition of the oxidative modification of LDL by nitecapone. Arterioscler Thromb Vasc Biol. 1995;15:740-747.
7. Nenseter MS, Halvorsen B, Rosvold O, Rustan AC, Drevon CA. Paracetamol inhibits copper-ion-induced, azo compound-initiated, and mononuclear cell-mediated oxidative modification of LDL. Arterioscler Thromb Vasc Biol. 1995;15:1338-1344.
8. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341-390.
9. Hazell LJ, Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J. 1993;290:165-172.
10. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun. 1992;17:9-20.
11. Chang GJ, Woo P, Honda HM, et al. Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of superoxide: dependence on pH and oxygen. Arterioscler Thromb. 1994;14:1808-1814.
12. Wieland E, Parthasarathy S, Steinberg D. Peroxidase-dependent, metal-independent oxidation of low density lipoprotein in vitro: a model for in vivo oxidation? Proc Natl Acad Sci USA. 1993;90:5929-5933.